Dr. Jason Suggett is a Pharmacist by training (in UK) who practiced in Hospital prior to completing a PhD in Pharmaceutics focusing on Tribo-electrification of powders with specific reference to Dry Powder Inhalers. He has also completed an MBA. His Pharmaceutical Industrial career started at 3M Health Care in the UK in the mid 90s where he worked within Inhalation Product Development and Programme Management in managerial roles for nearly 10 years before joining IVAX / TEVA and working in both Global and European development and commercial roles. Jason then moved to Hovione Farma-Ciencia in Portugal as Director of Pharma Operations responsible for all Drug Product Development with specific focus upon inhalation. He joined Trudell Medical International in the summer of 2012 as Group Director, Science and Technology, his group being responsible for New Product Development, Aerosol Science and Medical Affairs. Throughout his career, Suggett has specialized in Inhalation Drug Delivery with expertise developed in MDI, DPI and Nebulized product development, including formulations, devices, registration and commercialization. Suggett currently serves on the USP, General Dosage Forms Expert Committee and Inhalation Sub-Committee.